A Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study Evaluating the Efficacy and Safety of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1)
Latest Information Update: 01 Aug 2024
At a glance
- Drugs YP P10 (Primary)
- Indications Dry eyes
- Focus Adverse reactions; Therapeutic Use
- Acronyms ICECAP; ICECAP 1
- Sponsors Yuyu
Most Recent Events
- 30 Jul 2024 Status changed from active, no longer recruiting to completed.
- 16 Jun 2023 Planned End Date changed from 1 Mar 2023 to 1 Aug 2023.
- 16 Jun 2023 Planned primary completion date changed from 1 Mar 2023 to 1 Aug 2023.